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Delayed Cutaneous Wound Healing in Mice Lacking
Solute Carrier 11a1 (Formerly Nramp1): Correlation
with Decreased Expression of Secretory Leukocyte
Protease Inhibitor
Thusanth Thuraisingam1,6, Hakeem Sam2,6, Jacques Moisan3, Yi Zhang4, Aihao Ding5 and Danuta Radzioch1
Control of macrophage functions by natural resistance-associated macrophage protein 1 (NRAMP1) has proven
to be important for murine resistance to several intracellular pathogens, including Mycobacterium bovis BCG
and Salmonella typhimurium, although the exact molecular mechanism of its action remains unknown. We
identified secretory leukocyte protease inhibitor (SLPI) as a novel candidate gene whose expression is
dependent on Nramp1 gene expression using B10A.Nramp1þ /þ and B10A.Nramp1/ macrophage cell lines in
vitro, as well as mice bearing the resistance alleles (wild type (WT)) of the Nramp1 and mice with an ablated
Nramp1 gene (knockout (KO)). We established that B10A.Nramp1þ /þ cells spontaneously expressed a 10-fold
higher level of SLPI messenger RNA (mRNA) compared to B10A.Nramp1/ expression. Similarly, protein
secretion was detected only in supernatants from B10A.Nramp1þ /þ macrophages. Induction of SLPI in
excisional cutaneous wounds and, most importantly, in macrophages infiltrating these wounds was significantly
higher in Nramp1 WT mice compared to KO mice. These differences in SLPI expression in vivo correlated with a
significant delay in the kinetics of wound healing in Nramp1 KO mice compared to WT controls. Taken together,
these results suggest for the first time that Nramp1 controls macrophage SLPI mRNA and protein expression,
and can also have an important effect on the kinetics of wound healing.
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INTRODUCTION
Secretory leukocyte protease inhibitor (SLPI), a 12 kDa
protein, is abundantly expressed in mucosal tissues, and
plays a major role as an inhibitor of a wide range of proteases,
including chymotrypsin, elastase, and trypsin (Eisenberg
et al., 1990). Apart from SLPI expression by the mucosal
tissues, effector cells of the immune system, such as
monocytes, macrophages (Odaka et al., 2003), and neutro-
phils (Sallenave et al., 1997), can also express SLPI. SLPI was
shown to display marked in vitro antibacterial activity,
specifically against Escherichia coli and Staphylococcus
aureus (Hiemstra et al., 1996), as well as antifungal activity
(Tomee et al., 1997). SLPI has attracted widespread interest
because of its ability to inhibit HIV infection independent of
its protease activity (McNeely et al., 1997). Furthermore, the
observation that HIV patients had increased levels of SLPI in
their saliva compared to noninfected patients reinforced the
anti-HIV activity of SLPI (Baqui et al., 1999). A recent finding
that SLPI inhibits HIV binding to the annexin II receptor on
macrophages has shed light on the potential mechanism by
which SLPI exerts its antiviral activity (Ma et al., 2004).
Various lines of evidence have implicated SLPI as an anti-
inflammatory molecule. Anti-inflammatory effects of SLPI
include its ability to block NF-kB activation during lung
inflammation (Lentsch et al., 1999), as well as its capacity to
block lipopolysaccharide (LPS) binding to the LPS receptor on
macrophages (Ding et al., 1999). Importantly, SLPI knockout
(KO) mice show increased susceptibility to LPS-induced
endotoxic shock (Nakamura et al., 2003). In addition to its
role in inflammation, SLPI has been shown to play a pivotal
role in wound healing in recent studies using SLPI-deficient
mice (Ashcroft et al., 2000).
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The solute carrier 11a1 (SLC11A1) gene, encoding for
natural resistance-associated macrophage protein 1
(NRAMP1) protein, was identified using positional cloning
as the autosomal dominant gene responsible for resistance to
intracellular pathogens (Vidal et al., 1993). This gene,
conferring resistance to Mycobacterium bovis BCG (Gros
et al., 1981), Leishmania donovani (Bradley et al., 1979), and
Salmonella typhimurium (Plant and Glynn, 1976), was
identified independently by three different groups. In mice,
two alleles of the Nramp1 gene have been described. The
wild-type (WT) Nramp1r allele, also called the resistance
allele, confers resistance to infection and has a glycine
residue at position 169, whereas the Nramp1s allele
conferring susceptibility has an aspartic acid residue at this
position (Vidal et al., 1996). In addition to conferring
resistance to intracellular pathogens, we have identified
Nramp1 as an important gene in host defense against
Candida albicans (Puliti et al., 1995).
Important insight into the possible functions of Nramp1
was gained with the identification of Nramp2 (Gruenheid
et al., 1995). Mice lacking Nramp2 were found to have a
phenotype of severe iron deficiency (Fleming et al., 1997),
which led to the eventual discovery that the Nramp2 gene
product acts as a divalent cation transporter (Gunshin et al.,
1997). The former observation, as well as the evidence
obtained from the analysis of the Nramp1 homologues, SFM1
and SFM2, from Saccharomyces cerevisiae, suggested that
the NRAMP1 protein may be involved in the transport of
divalent cations, such as Mn2þ , Zn2þ , or Fe2þ , across the
membrane (Supek et al., 1996). Subsequently, NRAMP1 has
been shown to localize to late macrophage phagosomal
compartments (Jabado et al., 2000). Apart from macrophages,
human neutrophils have also been shown to express Nramp1
(Canonne-Hergaux et al., 2002).
Besides its role as a divalent cation transporter, Nramp1
has been strongly implicated in regulating macrophage
activation and cytokine release during innate immune
responses. For example, compared to Nramp1s controls,
Nramp1r-bearing peritoneal macrophages were found to
produce significantly greater quantities of inducible nitric
oxide synthase-mediated nitric oxide production in response
to LPS, tumor necrosis factor (TNF)-a or IFN-g, either
individually or in combination (Barrera et al., 1994).
Furthermore, expression of the Nramp1r gene allele was
found to correlate with a higher level of macrophage
activation, indicated by a greater expression of major
histocompatibility class II antigens on murine bone marrow-
derived macrophages (Wojciechowski et al., 1999).
Despite a tight linkage between the expression of Nramp1
and important biological functions of macrophages, the exact
molecular mechanism of this association remains unknown.
A major area of research interest for our laboratory is the
genetic regulation of macrophage functions in innate
immunity, particularly, the role of the Nramp1 in genetic
regulation of macrophage function. For such genetic studies,
we have at our disposal B10.A(Nramp1r) mice, which express
a resistance allele of the SLC11A1 gene, and B10.A
(Nramp1/) mice, which have the SLC11A1 gene functionally
disrupted, as well as bone marrow-derived macrophage cell
lines from both of these mice (Radzioch et al., 1991). The
main objective of the present study was to identify candidate
murine macrophage genes that are differentially expressed
based on the corresponding Nramp1 genotype. We report
a novel and strong association between the genotype of
Nramp1 on one hand, and the capacity of murine macro-
phages to produce SLPI on the other. Moreover, we show
for the first time a significant role for Nramp1 in the kinetics
of excisional cutaneous wound healing by mechanisms
that correlate with Nramp1-dependent macrophage SLPI
production.
RESULTS
Nramp1-mediated regulation of SLPI gene expression in
macrophages
The ability of Nramp1 to modulate the gene expression of
cytokines such as TNF-a, inducible nitric oxide synthase and
IL-1b has previously been shown to play a key role in host
defense against various intracellular pathogens (Barrera et al.,
1994; Radzioch et al., 1994; Ables et al., 2001). To uncover
additional candidate genes whose function may be critically
dependent on Nramp1, microarray messenger RNA (mRNA)
expression analysis of RNA isolated from unstimulated
B10A.Nramp1þ /þ and B10A.Nramp1/ macrophage cell
lines was performed. The list of selected genes that are
differently expressed between the two cell lines are presented
in Table 1. One of the genes that was spontaneously
expressed at significantly higher levels in B10A.Nramp1þ /þ
versus B10A.Nramp1/ macrophage cell lines was SLPI.
Since the SLPI gene was shown to have a profound effect on
regulation of gene expression in macrophage and other cell
types, it was selected for further analysis using a variety of
independent quantitative approaches. In order to adequately
characterize the association between SLPI gene expression
and the Nramp1 genotype, both in vitro and in vivo
experiments were performed. First, to detect quantitative
differences in SLPI mRNA expression, isolated RNA from
unstimulated B10A.Nramp1þ /þ and B10A.Nramp1/
macrophage cell lines was subjected to quantitative real-
time PCR analysis using primers specific for the SLPI gene.
Compared with B10A.Nramp1/ macrophage cell lines,
B10A.Nramp1þ /þ macrophage cell lines expressed a 10-fold
higher level of SLPI mRNA in cell culture under unstimulated
conditions (Figure 1a, Po0.001).
Secondly, it was important to determine whether the
relationship between the macrophage Nramp1 genotype and
spontaneous SLPI expression by macrophage cell lines at
the mRNA level also correlated with increased SLPI protein
expression. To address this question, SLPI protein levels
secreted into 24-hour culture supernatants from unstimulated
macrophage cell lines of both strains were subjected to
immunoprecipitation using antibodies specific for murine
SLPI, and were subsequently analyzed by gel electrophoresis.
As shown in Figure 1b, macrophages derived from KO mice
were deficient in SLPI protein expression. The identity of
the migrating band was confirmed to be SLPI by the size of the
protein indicated by the included protein ladder. In addition,
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Table 1. Genes selected from Microarray analysis of unstimulated Nramp1+/+ and Nramp1-/- macrophage cell line
Gene Arbitrary expression value WT Arbitrary expression value KO Fold
WT4KO
Coagulation factor V 1,223.87 9.75 125.56
SLPI 2,815.02 50.46 55.79
Cathepsin F 1,640.75 52.18 31.45
Expressed sequence C86322 285.35 9.75 29.27
Expressed sequence AV378681 9,604.29 518.33 18.53
Inositol 1,4,5 triphosphate receptor 5 736.78 155.39 4.74
Protocadherin alpha 6 637.57 159.97 3.99
Chemokine receptor (C-C) 1 376.75 128.44 2.93
Flotillin 1 1,814.07 719.59 2.52
RAN binding protein 16 1,208.27 1,050.43 1.14
Interleukin 16 212.34 193.23 1.10
WT oKO
Lymphocyte antigen 6 complex, locus A 201.19 2,331.35 11.59
Cathepsin K 226.83 2,606.00 11.49
Expressed sequence R74996 608.04 5,568.64 9.16
ADP-ribosylation-like factor 6 interacting protein 500.47 3,838.19 7.67
H2B histone family, member S 98.65 411.11 4.17
Ring-finger protein 13 358.36 1,072.79 2.99
Ubiquitin-specific protease 18 286.46 814.77 2.84
Transforming growth factor b 1 3,028.47 4,373.72 1.44
Tumor necrosis factor 537.26 632.43 1.18
CD68 antigen 10,551.73 12,028.30 1.14
Annexin A1 7,671.50 8,220.51 1.07
WT=KO
Poly A binding protein, cytoplasmic 1 17,774.03 17,778.36 1.00
Ribosomal protein L8 26,750.91 26,786.76 1.00
Cyclin T1 716.16 712.71 1.00
Thrombospondin 1 52.39 52.18 1.00
GTP-binding protein 3 4,332.04 4,326.70 1.00
Ornithine decarboxylase structural 1,417.82 1,414.52 1.00
Lamin A 24,809.08 24,779.06 1.00
Adenylate kinase 4 469.26 469.02 1.00
Ribosomal protein S16 26,029.61 26,072.03 1.00
Ribosomal protein S12 25,110.59 25,209.67 1.00
Trans-acting transcription factor 3 1,418.38 1,416.24 1.00
KO=knockout; SLPI=secretory leukocyte protease inhibitor; WT=wild type. Nramp1+/+ or Nramp1/ macrophage cell lines were cultured and RNA was
extracted using Trizol reagents. RNA quality was assessed using Agilent capillary electrophoresis and subjected to Affymetrix A74A microarray analysis of
gene expression. There were 5,328 genes expressed high enough (relative optical density values above 200) to allow reliable comparison. The difference in
SLPI gene expression (bold) between the two cell lines was the second highest among the genes differently expressed between the two types of cell tested. In
all, 10 genes were selected to illustrate the range of the differences in the gene expression between the two cell lines: 10 genes with expression higher in WT
compared to KO, 10 genes with expression higher in KO than WT, and 10 genes displaying no significant differences in gene expression between the two
cell lines.
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human recombinant SLPI migrated to the same molecular
weight band as the immunoprecipitated native SLPI protein
(Figure 1b).
We have previously demonstrated that B10A.Nramp1þ /þ
macrophages and macrophages derived from mice carrying
defective Nramp1 alleles produce very similar amounts of
TNF-a protein under unstimulated conditions (Puliti et al.,
1995). Therefore, as a control we analyzed the expression of
TNF-a constitutively secreted by the two cell types and, as
expected, we found that there were low levels of TNF-a
protein present in the supernatants and no difference in
secretion of TNF-a protein between the wild type (WT) and
KO cells was found (Figure 1c). As a further control,
B10A.Nramp1þ /þ and B10A.Nramp1/ macrophage cell
lines were also analyzed for their expression of p38 protein,
which is constitutively expressed to a similar extent by each
of these two macrophage cell lines. Since P38 protein is
expressed intracellularly, 2-hour adherent macrophages of
both strains were lysed and the total intracellular protein was
subjected to Western blot analysis to determine the level of
p38 protein expression. As expected, P38 protein expression
was not significantly different between B10A.Nramp1þ /þ
and B10A.Nramp1/macrophage cell lines (Figure 1d).
Taken together, spontaneous production of similar quantities
of TNF-a and P38 protein by B10A.Nramp1þ /þ and
B10A.Nramp1/ indicates that the dependence of SLPI
protein expression on the Nramp1 genotype is specific and
that B10A.Nramp1/ macrophage cell lines are not globally
deficient in the production of unrelated proteins whose
expression is not associated with Nramp1.
Delayed course of wound healing in Nramp1-deficient mice
Various studies indicate that SLPI expression is upregulated in
vivo during the early phase of wound healing (Ashcroft et al.,
2000; Lai and Pittelkow, 2004). In addition, SLPI-null mice
show a significant delay in the kinetics of wound healing,
suggesting that this protease inhibitor is essential for the
normal course of wound healing (Ashcroft et al., 2000).
Among the early inflammatory cells recruited to the site of
cutaneous wounds, macrophages have been shown to be of
major importance for a normal course of healing (Crowther
et al., 2001; Dipietro et al., 2001; Low et al., 2001). Putting
together the above reports with our own observations of the
strong association between SLPI expression and the Nramp1
genotype, we therefore hypothesized that the Nramp1 gene
may be involved in the mechanism of cutaneous wound
healing through its effects on macrophage gene expression
and function. To specifically address this hypothesis, WT and
KO mice were subjected to full-thickness cutaneous wounds
and the course of wound healing was evaluated.
Immediately post wounding (day 0), wound areas were not
significantly different between the two mice strains (Figure
2a). As early as day 2, WT mice had significantly smaller
wound areas (P¼0.034). This difference remained statisti-
cally significant on days 4, 6, 8, and 10 post-wounding
(P¼0.002 to 0.012). Beyond day 10, KO mice wound areas
appeared to gradually approximate those of WT mice and by
day 14 wounds from both strains of mice were healed. Thus,
compared with WT mice, there appeared to be a statistically
significant delay in the kinetics of wound healing in KO mice
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Figure 1. Analysis of SLPI mRNA and protein expression in vitro. 5.0106
cells (from Nramp1þ /þ or Nramp1/ macrophage cell lines) were cultured
and RNA was extracted using Trizol reagents. (a) Relative SLPI mRNA levels
(mean7SEM of four independent experiments, statistical analysis by unpaired
Student’s t-test) from these cells were quantitated using real-time quantitative
PCR. (b) Secreted SLPI protein in supernatants from 24-hour unstimulated
macrophage cell line cultures was immunoprecipitated and subjected to
Western blot analysis along with human recombinant SLPI protein as a
control (representative bands from four independent experiments are shown).
(c) Secreted TNF-a (mean7SEM of four independent experiments, statistical
analysis by unpaired Student’s t-test) was quantitated by ELISA in 24-hour
unstimulated macrophage cell line cultures. (d) Total p38 protein expression,
determined by Western blot analysis, in 2-hour adherent macrophage cell line
cultures (representative bands from one of four independent experiments are
shown).
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Figure 2. Delay in cutaneous wound healing in B10A.Nramp1-KO mice.
(a) Wound areas measured in WT (’) and KO (&) mice are plotted for time
points post-wounding. (b) Representative kinetics of wound healing illustrat-
ing comparative analysis of WT and KO mice is illustrated. The ruler was
included in each photograph to show the relative size of the wounds.
Macroscopically, the wounds of the WT mice (top) healed faster than wounds
of the KO mice. (c) Cumulative number of mice healed (below 1 mm in
wound diameter) at the indicated days post-wounding. Results are
mean7SEM, n¼ 19, for each time-point and group. Statistical analysis was
carried out using a rank sum test in comparison to WT mice. *Po0.03,
**Po0.002.
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during the first 10 days post-wounding, suggesting altered
mechanisms of healing in these mice. Figure 2b shows
the macroscopic appearance of wounds from WT and KO
mice as observed at days 0, 6, 10, and 14 post-wounding
(representative samples). On an individual mouse basis, the
total number of days required to heal wounds was quite
variable between days 10 and 14. For example, at day 12,
although the mean wound area was not statistically different
between WT and KO mice (Figure 2a), the number of mice
with wounds less than 1 mm (arbitrarily defined as comple-
tely healed) was higher in WT compared with KO. In
percentage terms at days 12 and 13 post-wounding, 79% (15/
19) and 89% (17/19), respectively, of WT mice were
considered fully healed, compared to 47% (9/19) and 63%
(12/19), respectively, in KO mice (Figure 2c). The total
median number of days to complete healing was 12 in WT
mice and 13 in KO mice.
Histological analysis of wound healing
To confirm the differences in the kinetics of wound healing
between Nramp1-WT and KO mice, wounds were also
analyzed histologically. At various days post-wounding,
wounds were excised with a clear margin, paraffin-
embedded, and further processed for histological studies.
Unwounded skin from both WT and KO mice showed
similar normal histoarchitecture with no epidermal acan-
thosis, similar numbers of adnexal structures, paucity of
inflammatory cell infiltrate, and subcutaneous fat layer (data
not shown). In contrast, in wounded skin, the margin of the
wounds was marked by significant acanthosis of epidermal
keratinocytes, as well as an influx of inflammatory cells into
the papillary and reticular dermis in the vicinity of the
wound, and forming a scale crust in the center of the wound
(Figure 3a and c).
In order to confirm whether differences in WT and KO
wound areas measured macroscopically correlated with
measurements at the microscopic level, the largest diameter
of the wounds on histology slide sections was measured using
a calibrated micrometer by an observer blinded to the strain
identity of the slides. Using this approach, we found a
statistically significant difference (P¼ 0.002) in the largest dia-
meter of wounds from WT (4.8970.56 mm) compared with KO
mice (8.9570.35 mm) (mean7SEM) at day 4 post-wounding
(Figure 3b).
Nramp1-dependent macrophage SLPI expression in vivo:
correlation with wound healing
Our hypothesis on the possible role of Nramp1 in cutaneous
wound healing had been based in part on the observation of
Nramp1-dependent expression of SLPI mRNA and protein in
vitro by B10A.Nramp1þ /þ . and B10A.Nramp1/ macro-
phage cell lines. Having confirmed quantitative differences in
the early kinetics of wound healing between WT and KO
mice, we then asked whether these differences could indeed
be correlated with differences in macrophage SLPI expression
in vivo. To determine whether the Nramp1 genotype affects
the control of SLPI expression in vivo, immunohistochemical
staining for SLPI was performed on paraffin-embedded
histological sections of excised wounds at various days
post-wounding using rabbit anti-mouse SLPI antibody.
By immunohistochemistry, SLPI protein was undetectable
in unwounded control skin from either WT or KO mice. As a
positive control for the specificity of antibody detection,
recombinant human SLPI, injected intradermally into the skin
of unwounded mice, was readily detected (Figure 4d). By day
4 post-wounding, SLPI protein expression was significantly
upregulated in vivo to a detectable level in both mouse
strains (Figure 4a). Four areas were identified where SLPI
staining occurred: within the scale crust at the center of the
wounds (A), submuscular region at the wound margin (B),
within keratinocytes at the acanthotic epidermal margin of
wounds (C), and in the non-acanthotic skin away from the
wound (D), indicated by a lack of epidermal acanthosis
(Figure 4a). Using semiquantitative scoring of staining
intensity in each of these specific regions on multiple
histological sections by an observer blinded to the strain
identity of the sections, SLPI staining was significantly greater
in WT compared to KO mice: 1.8 vs 0.4, Po0.001 for region
A; 3 vs 0.4, Po0.001 for region B; 3.7 vs 1.8, Po001 for
region C; 2 vs 0.25, Po0.006, for region D (Figure 4c).
Next, we examined skin sections at high power under oil
immersion to determine whether macrophage SLPI expres-
sion in healing wounds was affected by the Nramp1
genotype. Macrophages were the predominant inflammatory
cell type (75–80% of nucleated cells) and were located in the
perivascular submuscular margin of wounds (region B,
Figure 4) in both mouse strains at day 4 post-wounding.
There were no significant strain differences in the total
number of macrophages infiltrating into the wound at this site
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Figure 3. Histological analysis of the wound. Hematoxylin and eosin staining
of the wound was used to observe the architecture and relative size of the
wounds at 4 days post-wounding. (a) Microscopic representation of longest
diameter of the wounds where the arrows point to the wound margins.
(b) A calibrated micrometer was used to measure the diameter of the wounds.
(c) There was a greater degree of acanthosis in wounds from WT mice
compared with the KO. Wound diameter was calculated by blinded observers
and results are mean7SEM, n¼ 4 for each strain of mice. Statistical analysis
was carried out using an unpaired Student’s t-test.
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(Figure 5a). Macrophages were further characterized as
positively or negatively staining for SLPI (Figure 5b). The
number of macrophages staining positively for SLPI was
significantly greater (92.073.0 vs 5.076.3, P¼ 0.029) in WT
compared to KO mice, whereas for negatively staining
macrophages the numbers were significantly greater in KO
compared to WT macrophages (141.2723.6 vs 78.678.14,
P¼0.029). Alternatively, the percentages of macrophages
staining positively for SLPI in the two mouse strains were
53.971.7 vs 3.474.3% (Po0.001), with a higher number of
macrophages from WT mice staining for SLPI. Keratinocytes
(region B, Figure 4) and a few other cell types, including
fibroblasts (region B, Figure 4), also stained positively for
SLPI, but these cells were not the focus of the present study.
TGFb expression during wound healing
It has been shown that the ablation of SLPI leads to enhanced
transforming growth factor b (TGFb) expression and results in
impaired wound healing (Ashcroft et al., 2000). Therefore, it
was important to establish whether the lack of detectable
induction of SLPI observed in KO mice during wound healing
would also correlate with overexpression of TGFb. As shown
in Figure 6a, there was no detectable expression of TGFb in
unwounded skin from WT mice. Weak, but detectable,
expression of TGFb was seen in unwounded skin from KO
mice (Figure 6b). This basal expression was dramatically
enhanced during wound healing, as illustrated in Figure 6d
(day 6 post wounding), whereas TGFb levels remained
undetectable in the wound margin of WT mice (Figure 6c).
This confirms the previous observation that low SLPI leads to
increased TGFb production.
Colocalization of SLPI in tissue macrophages
It has been well established that macrophages are the major
cell type infiltrating wounds at late stages of healing, and that
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200
180
160
140
120
100
80
60
40
20
0
N
um
be
r o
f c
el
ls
N
um
be
r o
f c
el
ls
180
160
140
120
100
80
60
40
20
0
Macrophage Lymphocyte Others
MSLPI+ MSLPI– LySLPI+ LySLPI– OSLPI+ OSLPI–
WT
KO
WT
KO
**
*
a
b
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Figure 6. Expression of TGFb on the wounded skin was higher in Nramp1
KO mice. (a, b) TGFb staining of normal skin or (c, d) day 6 wounded skin
from (a,c) WT and (b,d) Nramp1 KO mice (original magnification 10).
Representative sections from three independent mice per strain are shown.
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macrophages are the major producers of SLPI. Furthermore,
the expression of Nramp1 gene is restricted to macrophages
in mice. Since our in vitro results demonstrate a strong
correlation between the macrophage Nramp1 genotype and
the ability to express SLPI, we assessed the tissue macro-
phages infiltrating the wounds for the presence of intracel-
lular SLPI protein by immunofluorescence microscopy.
Cryostat sections from 4-day-old wounds and unwounded
skin were obtained and were costained for macrophages and
SLPI with rabbit anti-mouse SLPI antibody combined with rat
anti-mouse F4/80. Control unwounded skin did not stain for
either SLPI or macrophages, and there was very minimal
background in wounded skin probed with secondary anti-
body alone (data not shown). There were similar levels of
macrophage staining in WT and KO mice (Figure 7,
macrophage panel), further confirming that Nramp1 does
not affect macrophage infiltration into the wounds. There
was a greater degree of staining for SLPI in WT wound tissues
than in KO tissues (Figure 7, SLPI panel). We observed very
minimal colocalization of macrophage surface marker F4/80
and SLPI in the wounds of the KO mice, while a strong
colocalization in the wounds of the WT mice was observed
(Figure 7, merge images). Taken together, these observations
demonstrate that NRAMP1 controls the expression of SLPI by
macrophages both in vitro and in vivo.
DISCUSSION
In this study, using in vitro and in vivo approaches, we have
found an important link, never described previously, between
an intact Nramp1 gene and macrophage mRNA and protein
expression of SLPI. Earlier work from our laboratory and
others indicated pleiotropic effects of Nramp1 on the priming
and activation of macrophages. For example, both transcrip-
tional and translational regulatory mechanisms were found
in the control of macrophage IA-b expression by Nramp1
(Barrera et al., 1997; Wojciechowski et al., 1999). Compared
with mock-transfected controls, transfection of macrophage
cell lines with a ribozyme that specifically cleaves Nramp1
mRNA resulted in significantly lower IFN-g, but not LPS-
activated production of nitric oxide, TNF-a and Ia (major histo-
compatibility class II) surface marker expression (Wojciechowski
et al., 1999). To determine novel macrophage candidate
genes whose expression might be differentially regulated
by Nramp1, we initially used gene microarray analysis as
a screening tool. For this analysis, we used RNA isolated
from non-activated adherent B10A.Nramp1þ /þ and B10A.
Nramp1/macrophage cell lines. We found that SLPI was
one of the genes that were spontaneously expressed at
a much higher level in B10A.Nramp1þ /þ than B10A.
Nramp1/ macrophages (Table 1).
We were particularly interested in the possible link
between Nramp1 and SLPI because, like Nramp1, SLPI has
been shown to be produced by macrophages, and it has
pleiotropic biological roles including antiviral, antibacterial,
and antifungal activities. Most importantly, knocking out the
SLPI gene in mice revealed that SLPI has nonredundant
functions that are necessary for cutaneous wound healing
(Ashcroft et al., 2000). To validate the results generated using
Affymetrix A74A gene expression array, we analyzed SLPI
gene expression both at the mRNA and protein levels, using
additional quantitative and independent methods, both in
vitro and in vivo. Using real-time reverse transcriptase-
quantitative PCR mRNA analysis, we demonstrated that, as
compared with B10A.Nramp1/ macrophage cell lines,
B10A.Nramp1þ /þ macrophage cell lines expressed 10-fold
higher level of SLPI mRNA in cells cultured under unstimu-
lated conditions (Figure 1a, Po0.001). Next, equivalent
numbers of B10A.Nramp1/ and B10A.Nramp1þ /þ macro-
phage cell lines were cultured for 24 hours and the quantity
of SLPI protein secreted into supernatants was analyzed
by immunoprecipitation and Western blotting. SLPI protein
was readily detectable only in supernatants from macrophage
cell lines with an intact Nramp1 gene, consistent with the
differences in SLPI mRNA expression detected earlier. In
contrast, the production of P38 protein by macrophage cell
lines was similar and independent of Nramp1. This was an
important control indicating that equivalent numbers of
B10A.Nramp1þ /þ and B10A.Nramp1/ macrophage cells
had been used for our in vitro assays and that there is a link
between Nramp1 and SLPI production.
We have also found significant differences between
Nramp1 WT and KO mice in the production of SLPI in vivo
during cutaneous wound healing. Using the tissue from day 4
cutaneous wounds, we demonstrated that SLPI protein levels
were significantly higher in WT compared with KO mice in
four distinct wound regions, namely the central scale crust,
migrating epidermal keratinocytes, submuscular region, and
dermis adjacent to the wound where there was no epidermal
acanthosis. The suprabasal keratinocyte localization of
SLPI expression post-wounding is consistent with previous
observations (Wingens et al., 1998; Ashcroft et al., 2000).
A difference in SLPI expression at the epithelial cell might
result from direct interaction between the epithelial cells and
macrophages, or might be mediated by a molecule secreted
WT
KO
F4/80
(macrophage) SLPI Merge
Figure 7. Intracellular localization of SLPI in tissue macrophages. At day 4
post-wounding, macrophages expressing SLPI in wounded tissue were
identified by double immunofluorescent staining. Fluorescence from
rhodamine identified similar levels of macrophage infiltration in both
strains of mice (F4/80 panel), while FITC fluorescence identified a higher
degree of SLPI in the wounds of the WT mice (SLPI panel). Costaining of SLPI
in tissue macrophages was observed in merged figures (merged panel)
(original magnification  40, n¼ 5 for each strain of mice).
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by the macrophage at the wound area; however, there are no
data available to eliminate one of these two possibilities.
Induction of SLPI production in vivo by glandular and
nonglandular epithelia, keratinocytes, and macrophages has
been described under a variety of conditions (Wingens et al.,
1998; Zhu et al., 2002; Nakamura et al., 2003). In patients
with Wegener’s granulomatosis, SLPI was detected in nasal
mucosa (Ohlsson et al., 2003). Higher levels of SLPI were
found in the saliva of patients infected with human
immunodeficiency virus compared to normal controls (Baqui
et al., 1999). Salivary SLPI may play an important role in
fighting oropharyngeal candidiasis (Chattopadhyay et al.,
2004). It was demonstrated that infection with Pseudomonas
aeruginosa induced SLPI production in the lungs within first 3
days post-infection (Jin et al., 1997, 1998). Our observation
that SLPI production is increased in vivo during cutaneous
wound healing is consistent with other studies showing SLPI
expression during the healing of mucosal and nonmucosal
cutaneous wounds (Wingens et al., 1998; Ashcroft et al.,
2000). Since Nramp1 is a macrophage-associated protein, we
were very much interested in establishing the functional
consequences resulting from the link between the Nramp1
and SLPI production. We found that the difference in SLPI
production between B10A.Nramp1þ /þ and B10A.Nramp1/
macrophage cell lines could also be clearly observed in the
case of primary macrophage-infiltrating cutaneous wounds.
Although the total numbers of wound-infiltrating macro-
phages at day 4 post-wounding were not significantly
different between WT and KO mice, we found that a
significantly higher percentage of macrophages from WT
mice stained positively for SLPI, confirming the significant
modulation of SLPI expression by the Nramp1 gene. We
confirmed these results by performing direct immunofluores-
cence studies on fresh frozen tissue sections of day 4 wounds
using an antibody to the macrophage-specific surface marker
F4/80 and a rabbit anti-mouse SLPI antibody. Using this
technique, we have been able to confirm that SLPI produc-
tion by wound-infiltrating macrophages in vivo is much
greater in WT compared to KO mice, similar to the in vitro
results derived using B10A.Nramp1þ /þ and B10A.Nramp1/
macrophage cell lines.
In the earlier work by Ashcroft et al.(2000), SLPI-null
mice showed impaired wound healing and enhanced TGFb
production in vivo. We found that reduced SLPI production
and enhanced TGFb expression in vivo by Nramp1 KO mice
correlated with a significant delay in the kinetics of wound
healing in these mice. To our knowledge, this is the first study
showing differences in cutaneous wound healing in mice
that is attributable to differences at the level of Nramp1
gene expression. Given the previously documented role
of Nramp1 in resistance against various infectious agents,
we excluded the possibility that infection was serving as
a contributing factor to our observed differences in kinetics
of wound healing between Nramp1 WT and KO mice by
carefully carrying out all experiments under specific patho-
gen-free (SPF) conditions and using animals bred in specific
pathogen-free facilities. Measurement of macroscopical
wound sizes could at times be affected by the presence of
extensive crusting, which could lead to an underestimate of
exact wound sizes. Despite this possibility, our measurements
of wound sizes were quite reproducible across several
independent experiments. We were also able to confirm
significant differences in wound healing between Nramp1
WT and KO mice at the histological level by measuring the
widest diameter of wounds with a micrometer. This was
performed by a blinded observer using multiple histological
sections from day 4 wounds. As seen with the macroscopic
wound area determinations, wounds were significantly wider
in KO compared with WT mice at day 4. Despite the initial
delay, Nramp1 KO mice were eventually able to heal their
wounds, suggesting an existence of alternative compensatory
Nramp1-independent mechanisms set in later that were able
to contribute to wound healing at the later time points.
Despite the correlation between the delay in the kinetics
of wound healing in Nramp1 KO mice and reduced SLPI and
enhanced TGFb production in vivo, we have yet to discover
the exact role and mechanism of Nramp1 in wound healing.
Future studies will be required to determine the exact nature
of the link between Nramp1 and SLPI expression; for
instance, it is possible that other intermediary genes may be
involved. Current evidence suggests that the modulation of
SLPI production by Nramp1 during cutaneous wound healing
is likely to be only part of a more complex network of
cytokines, chemokines, angiogenic, and growth factors, such
as TGFb, that contribute to wound healing. Our laboratory as
well as other investigators have previously reported that
Nramp1 is required for macrophage activation following
phagocytosis, the generation of reactive oxygen species
(Barton et al., 1995), and the release of the proinflammatory
cytokines such as TNF-a during innate immunity (Matte et al.,
2000). Exposure of the macrophage cell line RAW264.7 to
apoptotic cells induced both SLPI and TNF-a production, but
the addition of IFNg inhibited SLPI and augmented TNF-a
production. Transfection of SLPI into RAW264.7 cells led to
suppression of TNF-a production in response to apoptotic
cells (Odaka et al., 2003). SLPI KO macrophages showed
increased IL-6 secretion and NF-kB activity after LPS
treatment, compared with SLPI WT macrophages (Nakamura
et al., 2003). Evidence of the important anti-inflammatory
role of SLPI comes from observations of increased mortality
from LPS-induced endotoxic shock in SLPI-deficient com-
pared with WT mice (Nakamura et al., 2003). TGFb has been
shown to be chemotactic for inflammatory cells during
cutaneous wound healing (Wahl et al., 1987).
In summary, using both in vitro and in vivo approaches,
we have discovered a novel dependence of macrophage SLPI
mRNA and protein expression on Nramp1. We have found,
for the first time, evidence for a role for Nramp1 in the
kinetics of cutaneous wound healing. This effect of Nramp1
on wound healing correlates with higher expression and
production of SLPI by tissue-infiltrating macrophages in
cutaneous wounds of WT compared with KO mice, and
higher TGFb protein at wound margins of the latter strain.
Interestingly, our results demonstrate for the first time that the
ablation of one gene (Nramp1), previously believed to be
involved only in regulation of host resistance to infections,
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can affect an entire cascade of regulatory proteins involved
in wound healing. Future studies should shed more light
on the molecular mechanism involved in the Nramp1 gene-
mediated regulation of SLPI expression. Understanding the
specific network of mediators involved in the role of Nramp1
in cutaneous wound healing might be very important in
designing novel therapies.
MATERIALS AND METHODS
Mice
Mice were either B10. A(Nramp1r), expressing the WT allele of the
SLC11A1 gene (WT), or B10.A(Nramp1/), which have a disrupted
SLC11A1 gene (KO). KO mice were generated from 129/J mice
carrying the SLC11A1 gene disruption. These mice were back-
crossed for 16 generations to the B10A.Nramp1r genetic background
as described previously (Moisan et al., 2001). Mice were bred
according to the Animal Care Committee protocol in the Montreal
General Hospital Research Institute Animal Facility under specific
pathogen-free conditions. All animal work was approved by the
Montreal General Hospital Animal care committee.
Macrophages
The macrophage cell lines derived from the bone marrow of WT and
KO mice, designated B10A.Nramp1þ /þ and B10A.Nramp1/
respectively, were immortalized using J2 retroviral vectors, as
described previously (Blasi et al., 1989). Both macrophage cell lines
express to a similar extent the functional and phenotypic character-
istics of mature primary bone marrow-derived macrophages
as demonstrated in several previous publications (Wojciechowski
et al., 1999; Moisan et al., 2001). They were cultured in Dulbecco’s
modified Eagle medium (Invitrogen, Carlsbad, CA) supplemented
with 6% heat-inactivated fetal bovine serum (Hyclone, Logan, UT)
and 1% penicillin/streptomycin antibiotic mixture (Invitrogen,
Burlington, Ontario). All experiments were performed at a cell
density of 0.5 106 cells/ml.
For macrophage cell counts in histological samples from day 4, a
total of 200 nucleated cells in three high-power fields (oil
immersion) were counted and the percentage of macrophages,
lymphocytes, or other cell types was determined. In addition, the
number of macrophages and other cell types staining positively for
SLPI by immunohistochemical analysis was recorded.
RNA extraction
Total RNA was extracted from 5 106 cells using TRIzol Reagent
(Invitrogen, Burlington, Ontario). The quality of the RNA was
assessed by electrophoresis in a 2.2 M formaldehyde 2% agarose gel
and then with a 2100 Bioanalyser with the RNA 6000 Nano LabChip
Kit (Agilent Technologies, Germany). The RNA samples were used
for microarray analysis only when they were of high quality and
integrity as determined by the Bioanalyser.
Microarray experiment
In all, 20 mg of RNA from each sample was reverse transcribed using
oligo-dT primers containing a T7 RNA polymerase-binding site. In
vitro transcription was performed on the resulting cDNA and the
resulting cRNA was biotinylated via incorporation of biotinylated
dUTP and dCTP. The cRNA samples were then fragmented in 40 mM
Tris acetate, 100 mM potassium acetate, and 30 mM MgCl2 (pH 8.1)
at 951C. cRNA was hybridized to the microarray (Affymetrix
GeneChips MG-U74Av2), and washed for 16 hours at 451C.
Following hybridization using biotin-labelled cRNA, the GeneChips
were stained with streptavidin-conjugated to fluorophore phyco-
erythrin and the intensity of the signal emitted by the fluorophore was
scanned with Hewlett-Packard’s Gene Array scanner. The hybridi-
zation assay and data collection were performed at the McGill
University and Genome Quebec Innovation Centre (Montreal,
Quebec). Affymetrix Analysis Microarray Suite MAS 5 software
was used to estimate the expression level for each probe set from the
recorded fluorescent intensity of 11 probe pairs. We limited the
comparison to 5,328 genes that had a mean expression above 200,
which is the established cutoff value for significant gene expression.
Quantitative real-time PCR
Residual DNA was digested from 1 mg of RNA obtained from cells
using a DNA-free Kit (Ambion, Austin, TX). A reverse transcription
reaction was then carried out using random primers from a two-step
Core Reagent Kit (Stratagene, Cedar Creek, TX) according to the
manufacturer’s protocol. Following the manufacturer’s protocol, 2ml
of the total 25 ml of the reverse transcriptase reaction was added to
50 ml Brilliant SYBER Green quantitative PCR Master Mix (Strata-
gene), and the cDNA was analyzed to check for the level of SLPI
expression, carried out by real-time quantitative PCR using the
MX4000 apparatus Stratagene). The primers 50-CTCAGGCAAGATG
TATGATG-30 (sense) and 50-TTTCCCACATATACCCTCAC-30 (anti-
sense) were used to amplify SLPI cDNA. The amount of cDNA was
calculated based on the threshold cycle (CT) value, and was
standardized by the amount of house-keeping gene using the
2DDCT method (Livak and Schmittgen, 2001):
DDCT¼ ðCT;Target  CT;GADPHÞ  ðCT ;Target  CT;GADPHÞðcalibrator avgÞ
where the ‘‘target’’ represents the gene of interest and the calibrator
represents the unstimulated KO cell lines. The expression of each
gene was standardized by reference to the expression of the house-
keeping gene, GAPDH. Melting curve analysis and agarose gel
electrophoresis were also performed. We also confirmed that a
single product of the expected length was amplified. Only primers
with an efficiency of 90% or higher were used.
Immunoprecipitation, Western blotting and TNF-a analysis
B10A.Nramp1þ /þ and B10A.Nramp1/ macrophage cell lines
were plated at a cell density of 0.5 106 cells/ml onto 24-well plates
(Sarstedt, Quebec, Canada). Supernatants from these cells were
collected after 24 hours and spun down at 12,000 r.p.m. to remove
any floating cells. Collected supernatants were mixed with 1 mg of
rabbit anti-mouse SLPI antibody generated as described previously
(Jin et al., 1997) and incubated at 41C for 1 hour. Subsequently, 20 ml
of protein A/G plus agarose beads was added (Santa Cruz
Biotechnologies, Santa Cruz, CA) and the mixture was allowed to
mix gently overnight at 41C. Supernatants were spun at 1,000 r.p.m.
for 5 minutes and were removed without disturbing the pellet. The
A/G plus bead–antibody complex was washed three times with 500ml
of immunoprecipitation buffer, followed by the addition of 50ml of
SDS-PAGE sample buffer with 2.5% 2-mercaptoethanol (Fisher,
Fairlawn, NJ). Samples were boiled and loaded on a 4–12% Bis–Tris
NuPAGE gel (Invitrogen, Burlington, Ontario). In addition to using
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the molecular weight marker SeeBlue Plus2s (Invitrogen, Burling-
ton, Ontario), human recombinant SLPI protein (Jin et al., 1997) was
run as a positive control. Following electrophoresis, semi-dry transfer
onto Immobilon-P membranes was performed (Fisher, Nepean,
Ontario, Canada). The membranes were subsequently blocked with
5% milk for 1 hour at room temperature and probed overnight with
polyclonal rabbit antibody against murine SLPI (Jin et al., 1998)
(1mg/ml dilution in 5% milk), followed by incubation with a solution
of anti-mouse IgG HRP-conjugated antibodies (1:10,000 dilution in
blocking buffer, 1 hour at room temperature). The signal was
visualized using ECL reagent.
For the analysis of constitutive p38 MAP kinase expression,
2 106 cells from the B10A.Nramp1þ /þ and B10A.Nramp1/
macrophage cell lines were plated in complete media onto six-well
plates (Sarstedt, Quebec, Canada), and allowed to adhere for 2 hours
at 371C. Prior to the addition of 300 ml of SDS-PAGE sample buffer
with 2.5% 2-mercaptoethanol, supernatants were removed and the
adherent cells were washed twice with sterile PBS (Invitrogen,
Burlington, Ontario). The plates were scraped and the samples were
boiled for 5 minutes. The lysates were subsequently sheered using a
26-G needle. The samples were analyzed by Western blot analysis.
The membranes were probed with rabbit anti-mouse p38 antibody
(Cell Signalling Technology, Beverley, MA) according to the
manufacturer’s protocol.
The concentration of TNF-a secreted into the culture media by
macrophages was determined by sandwich ELISA as described
previously (Sheehan et al., 1989).
Wound-healing model
WT and KO mice, 8–10 weeks old were used for all in vivo
experiments. The chosen area of mouse dorsal skin destined for
excisional wounding was first shaved. An aseptic technique was
utilized for all surgical manipulation on mice. The skin was prepared
with a 70% alcohol solution prior to surgery. General anesthesia was
obtained by placing mice for 2–3 minutes in an isoflorane-filled
chamber with a steady inflow of oxygen. Single 6 mm full-thickness
round to oval cutaneous excisional wounds were made using a
sterile skin biopsy punch (Acuderm INC, Fort Lauderdale, FL).
Wounds were left to heal by secondary intention (Ashcroft et al.,
1999). Wounded mice were monitored daily and the wounds were
measured with sterile callipers. Wounds were considered fully
healed when the largest width of the wound measured was
p0.1 mm (lowest limit of calibration of callipers).
Histology and immunohistochemistry
Wounded tissues were harvested, fixed in 10% buffered formalin,
dehydrated, bisected, mounted in paraffin, and sectioned for
histology and immunohistochemistry. Deparaffinized and hydrated
sections were stained using hematoxylin and eosin. Immunohisto-
chemistry was performed with antibodies specific for SLPI and active
TGFb using rabbit anti-mouse SLPI (1 mg/ml) (Jin et al., 1997) or
rabbit anti-mouse TGFb1, -b2, -b3 (1:50, R&D systems, Minneapolis,
MN), respectively. Briefly, primary antibody-coated slides were
incubated for 60 minute, followed by three 20-minutes washes in
Tris-buffered saline–0.05% Tween 20, and then incubated with
secondary antibody for 30 minutes at room temperature. Slides were
then incubated with avidin–biotin–horseradish peroxidase com-
plexes (ABC, Vector Laboratories, Burlingame, CA) for 30 minutes.
Color was developed with Fast Red chromogen (Sigma-Aldrich,
Oakville, Ontario) in Tris buffer, and the slides were counterstained
with Harris hematoxylin (EM Science, Gibbstown, NJ). Negative
controls, consisting of all other elements except the primary
antibody, were included in all immunohistochemical analyses. Skin
samples consisting of normal skin injected subcutaneously with 50 ml
of varying concentrations (100, 50, 25, and 1 ng/ml) of human
recombinant SLPI (Jin et al., 1997) were processed to indicate
specificity of recognition by the rabbit anti-mouse SLPI in a dose-
dependent manner. All histology and immunohistochemistry was
performed on multiple sections from individual mice from three
independent in vivo wounding experiments and isotype antibody
control was included in each immunohistochemistry staining. The
intensity of immunohistochemical staining for SLPI was evaluated
independently by two blinded observers using the following scale: 0;
no staining, 1; weak or faint staining, 2; medium staining, 3; strong
staining, 4; very strong staining.
Direct immunofluorescence analysis
For double immunofluorescent staining, 4-day wounds were
harvested, bisected, and immersed in 4% paraformaldehyde in
0.1 M phosphate buffer overnight, followed by cryoprotection over-
night at 41C in 30% sucrose 0.1 M phosphate buffer. Serial cryostat
sections (12 mm) were obtained and were washed three times in PBS
for 5 minutes, followed by 1-hour blocking at room temperature with
blocking solution (10% normal goat serum, 10% normal donkey
serum in PBS 0.1% Tween 20s (Fisher, Fairlawn, NJ)). The sections
were then incubated overnight at room temperature with rabbit anti-
mouse SLPI (2mg/ml) (Jin et al., 1997) combined with rat anti-mouse
F4/80 (5 mg/ml, clone CI:A3-1; Serotech, Raleigh, NC) in blocking
solution. Following washes in PBS, sections were incubated with
Alexa Fluors 594-conjugated donkey anti-rat antibody (1:200,
Molecular Probes, Eugene, OR) for 1-hour at room temperature,
followed by 1-hour incubation with fluorescein-conjugated goat
anti-rabbit antibody. Slides were mounted with VECTASHIELDs
hardest mounting media with DAPI (Vector, Burlington, Ontario).
Images were captured with a Retiga 1300 C digital camera
(QImaging Corp., Burnaby, British Columbia), and all sections were
analyzed with the BioQuant Nova Prime image analysis system
(BioQuant Image Analysis Corp., Nashville, TN) using a Zeiss
AxioSkop II (Carl Zeiss Canada Ltd., Toronto) microscope.
Statistical analysis
SigmaStat software (SPSS, Chicago, IL) was used to calculate
statistical significance. For normally distributed data groups, the
Student’s t-test was used. Non-normally distributed data were
evaluated using a nonparametric rank sum test. Potential differences
among various groups were considered significantly different from
the others for P-values lower than 0.05.
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